|
 PharmaNet Development Group, a global, drug development services company, provides clinical development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development studies.
PharmaNet offers a comprehensive range of services for early stage programs, including Phase I/IIa and bioequivalence studies and bioanalytical services. Our global network of resources includes three clinics and two bioanalytical laboratories.
For Phase II–IV, PharmaNet offers a comprehensive range of clinical development services. Dedicated specialty teams conduct studies in virtually all therapeutic and specialty areas, including oncology, cardiology, dermatology, infectious diseases, neurosciences, ophthalmology, women’s health and pediatrics. These PharmaNet teams have the capabilities and dedicated resources to implement programs of any scale from regional to global.
Our dedicated Phase IV Development team has extensive experience in (Phase IIIb–IV) surveys, registries, and programs. PharmaNet professionals are experts at handling the complexities of late phase studies and are able to design and execute studies that meet the highest standards of scientific integrity and regulatory compliance while meeting commercial objectives.
PharmaNet consulting professionals are available to assist clients in the navigation of the clinical development process. Senior-level leaders with established credentials, proven experience and insight acquired through working with US and international regulatory agencies provide product development expertise, identify risk and develop risk minimization strategies, respond to changes in the regulatory environment and address challenges throughout the development process.
|
